ERBB2 and neoplasm: It has been reported that AKT/FOXO3A signaling pathway is responsible for p110αH1047R-, K-RasG12V-, H-RasG12V-, and Her2-mediated suppression of ΔNp63α expression and promotion of cancer cell motility and tumor metastasis [13].